Apistan 824 mg Bee Hive Strip
Tau Fluvalinate
Last verified
Veterinary medicinal product: bee-hive strip. Distribution category: AVM-GSL (Veterinary Medicines Regulations 2013, Schedule 3). Active substance: Tau Fluvalinate.1
In short: questions and answers
- Does Apistan 824 mg Bee Hive Strip need a prescription?
- Over the counter. As stated in the registration decision.1
- Which animals is Apistan 824 mg Bee Hive Strip for?
- Honey bees.1
- What is the active substance in Apistan 824 mg Bee Hive Strip?
- Tau Fluvalinate. ATCvet code: QP53AC10.13
- What is the withdrawal period of Apistan 824 mg Bee Hive Strip according to the leaflet?
- Honey bees, honey: 0 days.3
- Dispensing
- Over the counter1
AVM-GSL: Authorised Veterinary Medicine - General Sale List. No prescription is needed and it may be sold by any retailer.12
Supplied without a prescription. As stated in the registration decision.
- Animal species
- Honey bees1
- Active substance
- Tau Fluvalinate
- ATCvet code
- QP53AC103
- Manufacturer
- Marketing authorisation holder: Vita (Europe) Limited
Withdrawal period
| Animal species | Product | days |
|---|---|---|
| Honey bees | honey | 03 |
Summary of product characteristics
Composition
Active substance:
Tau fluvalinate 824 mg/strip
Excipients:
| Qualitative composition of excipients and other constituents |
|---|
| Polyvinylchloride |
| Bis (2-ethylhexyl) phthalate |
| Butylbenzyl phthalate |
| Epoxidized soybean oil |
| Stearic acid |
Bee hive strip
8g polymer strip measuring approximately 25 x 3 x 0.075 cm.
Pharmacological properties
4.1 ATCvet code :
Pharmacotherapeutic group:
Antiparasitic products, insecticides and repellents, Ectoparasiticides, including insecticides and repellents, Ectoparasiticides for topical use, including insecticides, Pyrethrins and pyrethroids, tau-fluvalinate.
ATC vet code: QP53AC10
4.2 Pharmacodynamics
Tau-fluvalinate is an ectoparasiticide of the cyano-pyrethroid class of compounds, which act by causing rapid depolarisation of the axonal membranes. The molecule is of low toxicity to honeybees in particular due to the poor fit of the molecule in potential receptor sites in this species. In Varroa destructor, uptake is rapid and death results from hyper-excitability and nervous exhaustion.
Tau-fluvalinate acts by contact. Molecules of the Active Pharmaceutical Ingredient migrate to the strip surface at a proscribed rate, determined by the reservoir loading of the polymer. Bees walk over the strips and pick up surface molecules of tau-fluvalinate. Varroa mites in contact with the bees are subjected to the molecule, which is lethal to mites but of relatively low hazard to bees.
The resistance mechanisms of Varroa mites to tau-fluvalinate can be explained by an increased detoxification due to the monooxygenases in the P450 system. Oxygenases appear to be important for the resistance of Varroa mites to tau-fluvalinate, whereas the influence of esterases appears to be negligible. Other mechanisms, such as the reduced uptake of active substance or modification of the binding site, could also be involved.
4.3 Pharmacokinetics
Although the target species for Apistan vet is the honeybee, the product acts directly upon the Varroa mites associated with the bees. There are no known pharmacokinetic effects in the bees.
Target species
The honeybee, Apis mellifera (L.)
Indications
Control of varroosis (Varroa destructor (formerly known as Varroa jacobsoni)) in honeybee colonies.
Dosage
Dose:
2 Apistan vet strips per brood chamber per beehive.
Administration:
Strips are suspended mid-way between the brood frames so that the bees can walk on both sides of the strip. One strip is suspended between frames 3 & 4 and the other between frames 7 & 8 within the brood chamber.
Treatment duration 6-8 weeks, after which time the strips must be removed and disposed of. The strips should not be removed from the hive for at least 6 weeks. Do not leave the strips in the hive for more than 8 weeks. The treatment period should be kept as short as possible in order to reduce the likelihood of trace residues in brood wax and to avoid the development of mite resistance.
Small and wintering bee colonies and nuclei require one strip only, suspended through the bee or brood cluster.
Strips should not be placed in the honey supers.
The efficacy is maximised if the product is used in late summer after the main honey harvest (when the amount of bee brood present is diminishing). However, in the case of severe infestations, Apistan vet can be used at any time of year.
Contraindications
None known.
Adverse reactions
Target species: The honeybee, Apis mellifera (L.)
None
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet, immediate packaging for respective contact details.
Warnings
Special precautions for safe use in the target species:
Tau-fluvalinate is a lipophilic compound which can accumulate in wax over repeated administrations. Therefore brood frames should be replaced with new foundation on a regular basis to avoid accumulation of residues. In addition, wax from treated colonies must not be recycled for use as foundation in brood or honey frames.
If signs of disease appear or persist then consult your veterinary surgeon or local bee inspector.
Special precautions to be taken by the person administering the veterinary medicinal product to animals:
This veterinary medicinal product can cause skin and eye irritation.
Avoid contact with skin, mouth and eyes.
Personal protective equipment consisting of gloves should be worn when handling the veterinary medicinal product.
Wash hands thoroughly with soap and water after handling strips or contaminated clothing.
Do not smoke, drink or eat during application.
Special precautions for the protection of the environment:
See section 5.5.
3.11 Special restrictions for use and special conditions for use, including restrictions on the use of antimicrobial and antiparasitic veterinary medicinal products in order to limit the risk of development of resistance
Not applicable.
Use during pregnancy, lactation or lay
Not applicable.
Interactions
None known.
Overdose
No treatment specified. In case of doubt, remove product from the colony.
Special warnings
Tau-fluvalinate resistance has been observed in some populations of Varroa. Therefore, where feasible, it is recommended to conduct appropriate testing (eg. Vita/NBU test or Beltsville test) to determine whether resistant mites are present prior to treating the colony.
It is recommended to monitor mite-fall before and after administration of the product to determine the effectiveness of the treatment, particularly when it has not been possible to conduct resistance testing prior to the treatment of the colony. It is not recommended to use the product in colonies where mites are known to be resistant to another pyrethroid treatment (e.g. flumethrin), since cross-resistance typically occurs. The product should be used as part of an Integrated Pest Management programme. It is recommended to alternate use with non-pyrethroid varroacides where possible.
Withdrawal period
Honey: zero days.
Do not use during honey flow.
Do not extract honey from the brood chamber.
Do not harvest honey when the treatment is in place.
To avoid accumulation of residues in wax, brood frames should be replaced with new foundation on regular basis.
Do not recycle wax from treated colonies for use as foundation in brood or honey frames.
Incompatibilities
None known.
Immediate packaging
Interior laminated foil pouch holding 10 Apistan vet strips; contained in outer paper pouch bearing the product label.
Storage
Keep strips in original, unopened packaging until ready to use.
This veterinary medicinal product does not require any special temperature storage conditions.
Protect from direct sunlight.
Store in original packaging only
Do not store strips near pesticides or other chemical substances which could contaminate the product
Store away from foodstuffs
Replace unused strips in the original packaging
Use strips for one treatment only - do not re-use strips
Shelf life
Shelf life of the veterinary medicinal product as packaged for sale: 3 years
Disposal of unused product
Medicines should not be disposed of via wastewater.
The veterinary medicinal product should not enter water courses as Tau fluvalinate is EXTREMELY DANGEROUS for fish and other aquatic organisms. Do not contaminate ponds, waterways or ditches with the strips or empty packaging.
Use take-back schemes for the disposal of any unused veterinary medicinal product or waste materials derived thereof in accordance with local requirements and with any national collection systems applicable to the veterinary medicinal product concerned.
Additional information
Vm 17017/5000
8 DATE OF FIRST AUTHORISATION
26 November 1998
9 DATE OF THE LAST REVISION OF THE SUMMARY OF THE PRODUCT CHARACTERISTICS
June 2026
10 CLASSIFICATION OF VETERINARY MEDICINAL PRODUCT
Veterinary medicinal product not subject to prescription.
Find more product information by searching for the ‘Product Information Database’ on www.gov.uk.
Gavin Hall Approved: 07 July 2026
Registration holder
Vita (Europe) Limited
Regulations
- Veterinary Medicines Regulations 2013 (SI 2013/2033), Schedule 32
Sources
- VMD Product Information Database: Apistan 824 mg Bee Hive Strip, 17017/5000
- The Veterinary Medicines Regulations 2013, Schedule 3 (categories of veterinary medicinal products)
- Summary of Product Characteristics: Apistan 824 mg Bee Hive Strip